|   | 
                  
                       | 
                      | 
                    
                        
                            
                                | 
                                  
                                 | 
                             
                             |  
                            
                                
                                    
                                        
  
    
	  | 
   
  
    
        
          |   | 
          
              
                | 
                    ÇÇ¿¥¿¡½º-ÀÌÇÁ¶óÆ®·ÎÇÇ¿ò³ªÀß½ºÇÁ·¹ÀÌ0.03%(ºê·ÒÈÀÌÇÁ¶óÆ®·ÎÇÇ¿ò)  PMS IPRATROPIUM NASAL SPRAY 0.03%[Ipratropium Bromide]  
                    
                 | 
               
              
                | 
                     Àü¹®ÀǾàǰ | »èÁ¦  
                        
                    	
                    
                 | 
               
              
                | 
					  
                  
				  
                 | 
               
              
              
              
              
              |   |  
              
                
                    
                        | 
                      ¾Ë¸²:  | 
                      µå·°ÀÎÆ÷¿¡¼´Â ÀǾàǰ ÀÎÅÍ³Ý ÆÇ¸Å¸¦ ÇÏÁö ¾Ê½À´Ï´Ù. | 
                     
                    | 
               
            
              
                
                   
                   
                   
                   
		   
                 | 
               
              
                | 
                  
                  
                 | 
               
              | 
            | 
         
       
       | 
   
    |  
  
    | 
      
     | 
     
  |                   
                                        | 
                                             | 
                                         
                            
                                
                            
                            
                              
                                                        
                              
                                                
                            
 |   
    | 
      
     | 
 
 |  
    
   
    | 
       
        À¯·áȸ¿ø °áÀç½Ã¿¡´Â º¸´Ù ´Ù¾çÇÑ ¾à¹°Á¤º¸¸¦
        ÀÌ¿ëÇÏ½Ç ¼ö ÀÖ½À´Ï´Ù.
        À¯·áÁ¤º¸¸ñ·ÏÀº Àü¹®È¸¿øÀ¸·Î
        ·Î±×ÀÎ ÇϽøé È®ÀÎ °¡´ÉÇÕ´Ï´Ù.
       
     | 
   
  
     | 
   
  
  
    
      
  
    
       |  
      
        
          
            
                | Çã°¡Á¤º¸ | 
             
           
         | 
       
       |  
      
  
    | Ç׸ñ | 
    ³»¿ë | 
   
  
  
  
  
   
    û±¸ÄÚµå(KDÄÚµå) ºñ±Þ¿©Á¡°ËÄÚµå  »óÇÑ±Ý¾× | 
    
      
      
        
        659600480[W11960271]  
	    
	    
            [º¸ÇèÄڵ忡 µû¸¥ ¾àǰ±âº»Á¤º¸ Á÷Á¢Á¶È¸] 
          
        
        
        
          
          
            \0 ¿ø/30ml/º´(2008.11.01)(ÇöÀç¾à°¡)
            \6,519 ¿ø/30ml/º´(2005.01.01)(º¯°æÀü¾à°¡)
        
          
            
	 
  	   
  	   
       
      
       
       
     
      
      
     
      
    
    
    
      
     [»óº´ÄÚµåÁ¶È¸]
      
      [Áúº´ÄÚµåÁ¶È¸]
     
     | 
   
   
    | ºü¸¥Á¶È¸ | 
    
      
     |   
   
  
  
  
   
    | Á¦Ç°¼º»ó | 
    Á¤·® ºÐ¹«½Ä ¿ë±â¿¡ µç ¹«»öÅõ¸íÇÑ ¾×Á¦  [Á¦ÇüÁ¤º¸ È®ÀÎ] |   
   
  
  
  
  
  
   
    | Æ÷À塤À¯Åë´ÜÀ§ | 
    10mg/mL¡¿1's.  | 
   
  
  
  
   
    | Æ÷À塤ÄÚµå´ÜÀ§ | 
    
        
        
            | ¾àǰ±Ô°Ý | 
            ´ÜÀ§ | 
            Æ÷ÀåÇüÅ | 
            ´ëÇ¥ÄÚµå | 
            Ç¥ÁØÄÚµå | 
            ºñ°í | 
	     
        
        
            | 30¹Ð¸®¸®ÅÍ | 
            1 °³ | 
            º´ | 
            8806596004802 | 
            8806596004819 | 
             | 
	     
        
         
     | 
   
      
  
  	
   
    | ÁÖ¼ººÐÄÚµå | 
    
      177105CSI  
      
	  [µ¿ÀÏÇÑ ÁÖ¼ººÐÄڵ带 °¡Áø ¿À¸®Áö³¯ ¶Ç´Â Á¦³×¸¯ ÀǾàǰ Á¶È¸]
     | 
   
  
  
  
 
  
  
    
  
  
  
  
  
  
  
  
  
  
 
  
  
  
 
  
  
  
  
  
  
   
    | Çã°¡»çÇ× ¿ø¹®Á¶È¸ | 
    
      
	    [Çã°¡»çÇ× ¿ø¹®Á¶È¸] 
     | 
   
  
  
  
  
     
  
  
  
   
    | È¿´ÉÈ¿°ú | 
    
    [ÀûÀÀÁõ º° °Ë»ö] 
      
    
     
	 
      ¾Ë·¯Áö¼º¡¤ºñ¾Ë·¯Áö¼º ºñ¿° ¹× ºñ·ç Ä¡·áÁ¦
      
     | 
   
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
    
  
  
  
  
  
   
    | ¿ë¹ý¿ë·® | 
    
      * Àý´ë ÀÓÀǺ¹¿ëÇÏÁö ¸¶½Ã°í ¹Ýµå½Ã ÀÇ»ç ¶Ç´Â ¾à»ç¿Í »ó´ãÇϽñ⠹ٶø´Ï´Ù. 
    
     
      
      
      [󹿾à¾î] 
      [ÁÖ¼ººÐÄÚµå:177105CSI ¿¡ µû¸¥ ½É»çÁöħ¿¶÷] 
 
[Á¦Çüº°º¹¾àÁöµµ]     
      	
     | 
   
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
   
    | ±Ý±â | 
    1) ¾ÆÆ®·ÎÇÉ(atropine)·ù, ¶Ç´Â ÀÌ ¾àÀÇ ºÎÇüÁ¦¿¡ °ú¹ÎÇÑ È¯ÀÚ.  
2) Çù¿ì°¢³ì³»Àå, Àü¸³¼± ºñ´ëÁõ ȯÀÚ  
 | 
   
  
  
  
  
   
    | ½ÅÁßÅõ¿© | 
    1) ¹æ±¤°æÆó»öÀÇ ¼ÒÀÎÀÌ Àִ ȯÀÚ.  
2) ³¶Æ÷¼º ¼¶À¯Áõ ȯÀÚ¿¡´Â À§Àå¿îµ¿Àå¾Ö°¡ À¯¹ßµÉ ¼ö ÀÖ´Ù.  
 | 
   
  
    
  
  
  
  
  
   
    | ÀÌ»ó¹ÝÀÀ | 
    
      1) È£Èí±â°è : ÀÌ ¾àÀÇ Åõ¿©·Î ºñ°ÃâÇ÷, ºñ°°ÇÁ¶ ¹× ºñ°Àڱذú °°Àº ±¹¼Ò¹ÝÀÀÀÌ ÀϾ ¼ö ÀÖ´Ù.  
2) Á¤½Å½Å°æ°è : µÎÅë °°Àº ºñƯÀÌÀûÀÎ ¹ÝÀÀÀ» À¯¹ßÇÒ ¼ö ÀÖ´Ù.  
3) ¼Òȱâ°è : ±¸¿ª, À§Àå¿îµ¿Àå¾Ö ȯÀÚ°¡ º¸°íµÈ ¹Ù ÀÖ´Ù.  
4) ±¸° : ±¸°¥, ÀÎÈİÇÁ¶°¡ ³ªÅ¸³¯ ¼ö ÀÖ´Ù.  
5) ¼øÈ¯±â°è : Ç÷°üºÎÁ¾, ½É°èÇ×Áø, ½É¹Ú¼ÓµµÁõ°¡ ȯÀÚ°¡ º¸°íµÈ ¹Ù ÀÖ´Ù.  
6) ÇǺΠ: ±¹¼ÒÀÚ±Ø(ÀÛ¿°¨), ÇǺιßÁø, µÎµå·¯±â¿Í °°Àº ¾Ë·¯Áö ÇüÅÂÀÇ ¹ÝÀÀÀ» À¯¹ßÇÒ ¼ö ÀÖ´Ù.  
7) ±âŸ : ¾È±¸ºÎÀÛ¿ë, ÀÜ´¢°¨ÀÌ ³ªÅ¸³¯ ¼ö ÀÖ´Ù.  
      
     | 
   
        
  
  
    
   
    | »óÈ£ÀÛ¿ë | 
    1) ÀϹÝÀûÀ¸·Î ¸¸¼ººñ¿°¿¡ ó¹æµÇ´Â Ç×È÷½ºÅ¸¹ÎÁ¦, ÃæÇ÷ Á¦°ÅÁ¦, ³×Àß½ºÅ×·ÎÀ̵åÁ¦ µî°ú ÀÌ ¾àÀ» º´¿ë 
Åõ¿©ÇßÀ» ¶§, ºÎÀÛ¿ëÀ» Áõ°½ÃŲ´Ù´Â º¸°í´Â ¾ø´Ù.  
2) ÀÌ ¾àÀº °ÅÀÇ Àü½ÅÈí¼ö°¡ µÇÁö ¾ÊÀ¸³ª ÀÌÇÁ¶óÆ®·ÎÇÇ¿ò ºê·Î¸¶ÀÌµå °æ±¸ÈíÀÔÁ¦¸¦ Æ÷ÇÔÇÏ¿© Ç×Äݸ°¼º 
Ä¡·áÁ¦¸¦ º´¿ë Åõ¿©ÇÑ °æ¿ì »ó°¡ÀÛ¿ëÀÌ ³ªÅ¸³¯ ¼ö ÀÖ´Ù.  
 | 
   
  
    
  
  
       	
  
     
  
  
  
  
  
   
    | Related FDA Approved Drug | 
    
       
     | 
      
  
  
  |  
     
   
  
    
       |  
      
        
          
            
                | Á¤º¸¿ä¾à |         
             
           
         | 
             	    
       |  
      | 
  
    µå·°ÀÎÆ÷ ÀǾàǰ ¿ä¾à/»ó¼¼Á¤º¸
    
  
  
    
  
   |  
     
   
  
    
       |  
      
        
          
            
                | ÄÚµå ¹× ºÐ·ùÁ¤º¸ |         
             
           
         | 
             	    
       |  
      | 	 |  
     
   
  
    
       |  
      
        
          
            
                | Á¦Ç°Á¤º¸ |            
             
           
         | 
             	  
       |  
       |  
     
   
  
    
       |  
      
        
          
            
                | º¹¾àÁ¤º¸ |            
             
           
         | 
             	  
       |  
      
  
    | Ç׸ñ | 
    ³»¿ë | 
   
   
    | LACTmed ¹Ù·Î°¡±â | 
    
      
        [¹Ù·Î°¡±â]
     | 
     
  
  
   
    | ¾à¸®ÀÛ¿ë | 
    
       
      À¯·áÁ¤º¸ÀÔ´Ï´Ù.
       
     | 
     
  
  
       
  
  
   
    | º¹¾àÁöµµ | 
    
     
    À¯·áÁ¤º¸ÀÔ´Ï´Ù.
    
     | 
   
                                                          															
  
   
  
  
   
    | ÀӺο¡´ëÇÑÅõ¿© | 
    
      
      
        
	      
	      
	        | *  | 
	        
	          ÀüüÀӽŠ±â°£º°·Î ¿©·¯µî±ÞÀÌ Á¸ÀçÇÒ ¼ö ÀÖÀ¸¸ç °¡Àå À§Çèµµ°¡ ³ôÀº Á¤º¸¸¸ º¸¿©Áý´Ï´Ù. ´Ü, º¹ÇÕÁ¦ÀÇ °æ¿ì ¸ðµç º¹ÇÕÁ¦¼ººÐ¿¡ ´ëÇÑ ÀÓºÎÅõ¿©µî±ÞÀÌ Ç¥½ÃµÈ°ÍÀº Àý´ë ¾Æ´Ï¸ç Ç¥½ÃµÈ°ÍÁß¿¡ °¡Àå À§Çèµµ°¡ ³ôÀº Á¤º¸¸¸ ³ªÅ¸³³´Ï´Ù. 
	         | 
	         
	       
	       | 
	   
	  
	    |   | 
	   
	  
	    
	      FDA : Bµî±Þ 
				        	
					  
					
	   | 
	  
	  
	  
	     
	     
	     
	     
	     
	     
	   | 
	 
	
	  
	      
	      
	        | *  | 
	        
	          »ó±â ÀÓºÎÅõ¿©¿¡ ´ëÇÑ Á¤º¸´Â Àü»êó¸® µÇ¸é¼ ÀÔ·Â ¿À·ù °¡´É¼ºÀÌ Á¸ÀçÇÕ´Ï´Ù. ¿À·ù °¡´É¼ºÀ» ÃÖ¼ÒÈÇϱâ À§ÇÏ¿© ¸¹Àº ³ë·ÂÀ» ±â¿ïÀ̰í ÀÖÀ¸³ª, ±× Á¤È®¼º¿¡ ´ëÇÏ¿© È®½ÅÀ» µå¸± ¼ö ¾ø½À´Ï´Ù. ÀÌ¿¡ ´ëÇØ ȸ»ç´Â Ã¥ÀÓÀ» ÁöÁö ¾Ê½À´Ï´Ù.
	         | 
	         
	      
	        | *  | 
	        
	          ¹Ýµå½Ã °ø½Å·Â ÀÖ´Â ¹®ÇåÀ» ´Ù½Ã Çѹø Âü°í ÇϽñ⠹ٶó¸ç ÀÇ»ç ¶Ç´Â ¾à»çÀÇ ÆÇ´Ü¿¡ µû¶ó Åõ¿©¿©ºÎ°¡ °áÁ¤µÇ¾î¾ß ÇÕ´Ï´Ù.
	         | 
	         
	       
	   | 
	 
       
     | 
   
  
  
  	   
  
  	   
  
  	   
  
  
     
      | Pharmacokinetics | 
      
       
      À¯·áÁ¤º¸ÀÔ´Ï´Ù.
      
       |   
     
  
  
  
  
  
  
  
   
    | º´¿ë±Ý±â ¹× ¿¬·É´ë±Ý±â ±Ù°ÅÁ¶È¸ | 
    
      [º´¿ë±Ý±â ¹× ¿¬·É´ë±Ý±â ±Ù°ÅÁ¶È¸]
     | 
   
  	
  
  
  	
  
  
  
   
    | º¸°ü»ó ÁÖÀÇ | 
    
      
    	
     | 
   
  
  
   
    | Á¶Á¦½Ã ÁÖÀÇ | 
    
      
    	
     | 
      
 
 |  
     
   
  
    
       |  
      
        
          
            
                | ½É»çÁ¤º¸ |            
             
           
         | 
             	  
       |  
       |  
     
     
  
    
       |  
      
        
          
            
                | ÇмúÁ¤º¸ |          
             
           
         | 
             	  
       |  
      
  
    | Ç׸ñ | 
    ³»¿ë | 
   
  
    | DUR (ÀǾàǰ»ç¿ëÆò°¡) | 
    º´¿ë±Ý±â :
     
	 °í½ÃµÈ º´¿ë±Ý±â ³»¿ëÀº ¾ø½À´Ï´Ù.
	 
	  [»óÈ£ÀÛ¿ë/º´¿ë±Ý±â°Ë»ö]										
	  ¿¬·É´ë±Ý±â :
      °í½ÃµÈ ¿¬·É±Ý±â ³»¿ëÀº ¾ø½À´Ï´Ù.
      
       [¿¬·É´ë±Ý±â»ó¼¼°Ë»ö]
       
       
        
        
     | 
   
  
   
    | Mechanism of Action | 
    
       Ipratropium¿¡ ´ëÇÑ Mechanism_Of_Action Á¤º¸ Ipratropium bromide is an anticholinergic agent. It blocks muscarinic cholinergic receptors, without specificity for subtypes, resulting in a decrease in the formation of cyclic guanosine monophosphate (cGMP). Most likely due to actions of cGMP on intracellular calcium, this results in decreased contractility of smooth muscle. 
     | 
   
  
   
    | Pharmacology | 
     
       Ipratropium¿¡ ´ëÇÑ Pharmacology Á¤º¸ Ipratropium bromide, a synthetic ammonium compound structurally similar to atropine, is used as a bronchodilator in the management of cholinergic-mediated bronchospasm associated with chronic obstructive pulmonary disease and in the treatment of rhinorrhea associated with the common cold or with allergic or nonallergic seasonal rhinitis. 
     | 
   
  
   
    | Absorption | 
    
       Ipratropium¿¡ ´ëÇÑ Absorption Á¤º¸ Inhalation (local)-minimal; Nasal-rapid and minimal 
     | 
   
  
   
    | Pharmacokinetics | 
    
       Ipratropium BromideÀÇ ¾à¹°µ¿·ÂÇÐÀÚ·á 
	- ±â°üÁöÈ®ÀåÈ¿°ú ¹ßÇö½Ã°£ : 1-3ºÐ
	
 - ÃÖ´ëÈ¿°ú ¹ßÇö½Ã°£ : 1.5-2 ½Ã°£ À̳»
	
 - ÀÛ¿ëÁö¼Ó½Ã°£ : 4-6 ½Ã°£±îÁö
	
 - Èí¼ö : ÆóÀÇ Ç¥¸éÀ̳ª À§Àå°üÀ¸·ÎºÎÅÍ Àü½Å¼øÈ¯À¸·ÎÀÇ Èí¼ö´Â °ÅÀÇ ¾øÀ½.
	
 - ºÐÆ÷ : ÈíÀÔ : ¿ë·®ÀÇ 15%°¡ Çϱ⵵¿¡ µµ´Þ
  
     | 
   
  
   
    | Toxicity | 
    
       Ipratropium¿¡ ´ëÇÑ Toxicity Á¤º¸ LD50=1001mg/kg (orally in mice) 
     | 
   
  
   
    | Drug Interactions | 
    
       Ipratropium¿¡ ´ëÇÑ Drug_Interactions Á¤º¸ Not Available 
     | 
   
  
   
    CYP450  Drug Interaction | 
    
      [CYP450 TableÁ÷Á¢Á¶È¸] 
     | 
   
  
   
    | Drug Target | 
    
      
      [Drug Target]
     | 
   
  
   
    | Description | 
    
       Ipratropium¿¡ ´ëÇÑ Description Á¤º¸ A muscarinic antagonist structurally related to atropine but often considered safer and more effective for inhalation use. It is used for various bronchial disorders, in rhinitis, and as an antiarrhythmic. [PubChem] 
     | 
   
  
   
    | Dosage Form | 
    
       Ipratropium¿¡ ´ëÇÑ Dosage_Form Á¤º¸ Aerosol, metered	NasalAerosol, metered	Respiratory (inhalation)Liquid	NasalLiquid	Respiratory (inhalation)Solution	NasalSolution	Respiratory (inhalation)Spray, metered	Nasal 
     | 
   
  
   
    | Drug Category | 
    
       Ipratropium¿¡ ´ëÇÑ Drug_Category Á¤º¸ AntimuscarinicsAntispasmodicsBronchodilator AgentsCholinergic Antagonists 
     | 
   
  
   
    | Smiles String Canonical | 
    
       Ipratropium¿¡ ´ëÇÑ Smiles_String_canonical Á¤º¸ CC(C)[N+]1(C)C2CCC1CC(C2)OC(=O)C(CO)C1=CC=CC=C1 
     | 
   
  
   
    | Smiles String Isomeric | 
    
       Ipratropium¿¡ ´ëÇÑ Smiles_String_isomeric Á¤º¸ CC(C)[N+]1(C)[C@@H]2CC[C@@H]1CC(C2)OC(=O)C(CO)C1=CC=CC=C1 
     | 
   
  
   
    | InChI Identifier | 
    
       Ipratropium¿¡ ´ëÇÑ InChI_Identifier Á¤º¸ InChI=1/C20H30NO3/c1-14(2)21(3)16-9-10-17(21)12-18(11-16)24-20(23)19(13-22)15-7-5-4-6-8-15/h4-8,14,16-19,22H,9-13H2,1-3H3/q+1/t16-,17-,18?,19?,21?/m1/s1 
     | 
   
  
   
    | Chemical IUPAC Name | 
    
       Ipratropium¿¡ ´ëÇÑ Chemical_IUPAC_Name Á¤º¸ [(1R,5R)-8-methyl-8-propan-2-yl-8-azoniabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate 
     | 
   
    
  |  
     
     
  
    
       |  
      
        
          
            
                | »ç¿ëÀÚÄÁÅÙÃ÷ |           
             
           
         | 
             	  
       |  
       |  
     
         
 
     | 
   
   
     | 
   
  
    
      
        
          
            
              - 
                ÃÖ±ÙÁ¤º¸¼öÁ¤ÀÏ 2021-12-09
              
 
              - 
                
                 º» ¼öÁ¤ÀÏ Á¤º¸´Â Çã°¡Á¤º¸ ÀÌ¿ÜÀÇ ±âŸÁ¤º¸ ¼öÁ¤ÀÏÀ» ÀǹÌÇϹǷÎ, Çã°¡Á¤º¸¼öÁ¤ÀÏÀº º»¹®¿¡ Ç¥±âµÈ ³¯Â¥¸¦ ÂüÁ¶ÇϽñ⠹ٶø´Ï´Ù.
                
              
     
             
         |                 
       
     |       
          
                
                    
                       ¾Ë¸² | 
                       
                      »ó¼¼Á¤º¸´Â ½ÄǰÀǾàǰ¾ÈÀüóÀÇ Á¦Ç°Çã°¡»çÇ×À» Åä´ë·Î ÀÛ¼ºµÇ¾úÀ¸¸ç ¿ä¾àÁ¤º¸´Â »ó¼¼Á¤º¸ ¹× ±âŸ¹®ÇåÀ» ±â¹ÝÀ¸·Î µå·°ÀÎÆ÷¿¡¼ ÆíÁýÇÑ ³»¿ëÀÔ´Ï´Ù. Á¦Ç°Çã°¡»çÇ×ÀÇ ¸ñÂ÷¿Í ´Ù¼Ò »óÀÌÇÒ ¼ö ÀÖ½À´Ï´Ù.  | 
                    
                    | 
               
      
      
                
                    
                       °æ°í | 
                     
                      µå·°ÀÎÆ÷ ÀǾàÇмúÁ¤º¸´Â ½ÄǰÀǾàǰ¾ÈÀüóÀÇ Á¦Ç°Çã°¡»çÇ×, Çмú¹®Çå, Á¦¾àȸ»ç Á¦°øÁ¤º¸ µîÀ» ±Ù°Å·Î ÀÛ¼ºµÈ Âü°í Á¤º¸ÀÔ´Ï´Ù. 
                          Á¤º¸ÀÇ Á¤È®¼ºÀ» À§ÇØ ³ë·ÂÇϰí ÀÖÀ¸³ª ÆíÁý»óÀÇ ¿À·ù, Çã°¡»çÇ× º¯°æ, Ãß°¡ÀûÀÎ Çмú¿¬±¸ ¶Ç´Â Àӻ󿬱¸ ¹ßÇ¥ µîÀ¸·Î ÀÎÇØ ¹ß»ýÇÏ´Â ¹®Á¦¿¡ ´ëÇØ µå·°ÀÎÆ÷´Â 
                          Ã¥ÀÓÀ» ÁöÁö ¾Ê½À´Ï´Ù. ÀÚ¼¼ÇÑ ³»¿ëÀº ¡°Ã¥ÀÓÀÇ ÇÑ°è ¹× ¹ýÀû°íÁö¡±¸¦ ÂüÁ¶ÇØ ÁֽʽÿÀ.
                            ¹Ýµå½Ã Á¦Á¶¡¤¼öÀÔ»ç, ÆÇ¸Å»ç, ÀÇ»ç, ¾à»ç¿¡°Ô ÃÖÁ¾ÀûÀ¸·Î È®ÀÎÇϽñ⠹ٶø´Ï´Ù.
                          ÀüÈ: 02-3486-1061 ¤Ó À̸ÞÀÏ: webmaster@druginfo.co.kr
 | 
  
                    | 
               
  
 
  
    ¾Æ·¡ÀÇ ³»¿ëÀ» Æ÷ÇÔÇÑ Àüü µ¥ÀÌÅ͸¦ º¸½Ã·Á¸é 
    ¿©±â·Î À̵¿ÇϽñ⠹ٶø´Ï´Ù.
   
  
 
  º´¿ë±Ý±â ¹× ƯÁ¤¿¬·É´ë ±Ý±â ¼ººÐ
 
  [ÀǾàǰº´¿ë/¿¬·É´ë±Ý±â °í½Ã±Ù°Å·Î ¹Ù·Î°¡±â]       Á¦¸ñ ¾øÀ½ 
 
    
    2008³â 8¿ù 1ÀÏ ¾à°¡ÈÀÏ»ó 8¿ù´Þ ½Å±ÔµîÀç ¹× »èÁ¦µÇ´Â ǰ¸ñ Æ÷ÇÔÇÑ º´¿ë¿¬·É ±Ý±â ǰ¸ñ¸®½ºÆ® ±âÁØ
    
    1. ÇöÀç °Ë»öÇÑ Á¦Ç°¿¡ ´ëÇÑ  º´¿ë±Ý±â Á¦Ç° Á¸Àç¿©ºÎ ¹× °Ë»ö
    ÇöÀç ÀÌÁ¦Ç°¿¡ ´ëÇÑ º´¿ë±Ý±â¿¡ ÇØ´çÇϴ û±¸Äڵ庰 Á¦Ç°³»¿ª °øÁö³»¿ëÀÌ ¾ø½À´Ï´Ù
          
    
    
    
    2. ¿¬·É´ë±Ý±â Á¸Àç¿©ºÎ
    ÇöÀç ÀÌÁ¦Ç°¿¡ ´ëÇÑ ¿¬·É±Ý±â¿¡ ÇØ´çÇϴ û±¸Äڵ庰 °øÁö³»¿ëÀÌ ¾ø½À´Ï´Ù
 
 
 
   
  |  
                           
                         | 
                       
                      | 
                   |